The Cannabidiol (CBD) Market size is expected to grow at an annual average of 21% during 2021-2027. The demand for cannabidiol (CBD) for medical and wellness purposes is high due to its healing properties, which are key factors driving the market growth. Additionally, increased product adoption and utilization due to government approvals is a major factor expected to drive demand for cannabidiol-infused products.
(Get 15% Discount on Buying this Report)
A full report of Cannabidiol (CBD) Market is available at: https://www.orionmarketreports.com/cannabidiol-cbd-market/37677/
The following segmentation are covered in this report:
By Type
- Hemp-derived Type
- Marijuana-derived Type
By Application
- Pharmaceuticals Industry
- Food Industry
- Cosmetics Industry
- Other
Company Profile
- ENDOCA
- Cannoid, LLC
- Medical Marijuana, Inc.
- Folium Biosciences
- Elixinol
- NuLeaf Naturals, LLC
- Isodiol International, Inc.
- Pharmahemp d.o.o.
The report covers the following objectives:
- Proliferation and maturation of trade in the global Cannabidiol (CBD) Market
- The market share of the global Cannabidiol (CBD) Market supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the Cannabidiol (CBD) Market
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Cannabidiol (CBD) Market
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
